Skip to main content
. Author manuscript; available in PMC: 2017 Oct 24.
Published in final edited form as: J Med Virol. 2008 Jan;80(1):72–79. doi: 10.1002/jmv.21043

TABLE I.

Comparison of Three NAT Assays for the Quantitation of HCV RNA in Chimpanzee-Derived Plasma Pools of the Six Major Genotypes and of Selected Subtypes

Genotype Virus strain log10 chimpanzee infectious doses/mla log10 IU/ml of HCV (N, SD)
HCV Monitor 2.0 HCV b-DNA 3.0 HCV TaqMan
1a H77C 3.5 4.8 (2, 0.04) 4.6 (2, 0.00) 4.4 (2, 0.07)
1a HC-TN 5 5.3 (2, 0.05) 5.0 (2, 0.01) 4.7 (2, 0.06)
1b HC-J4 3 4.7 (3, 0.05) 4.4 (2, 0.00) 4.4 (4, 0.12)
2a HC-J6 4 5.0 (3, 0.07) 4.5 (2, 0.02) 4.7 (4, 0.10)
2b HC-J8 4 4.6 (2, 0.13) 4.0 (3, 0.04) 4.0 (4, 0.42)
3a S52 3 4.3 (3, 0.02) 3.8 (2, 0.00) 4.0 (4, 0.49)
4a ED43 5 5.6 (3, 0.05) 5.6 (2, 0.04) 5.4 (4, 0.30)
5a SA13 4 5.1 (2, 0.00) 4.8 (2, 0.01) 4.4 (4, 0.57)
6a HK-6a 3 4.9 (2, 0.05) 4.5 (2, 0.00) 4.2 (3, 0.41)

Plasma pools were evaluated in two or more independent tests by the HCV Monitor 2.0, the Versant HCV RNA 3.0 b-DNA and our in-house HCV TaqMan assays and yielded results that were not significantly different (P = 0.069) based on analysis of variance. The plasma pools, representing the six major genotypes of HCV, all yielded values that were within the linear testing ranges of all three assays.

a

Except for HCV strain H77C, titers were obtained by reverse titration in single chimpanzees and are therefore approximate.